India Pharma
Dr. Reddy’s Laboratories
This high-flying drug company, India’s third largest, reported a tripling of net income to $42.5 million in the fourth quarter and specializes in selling and exporting versions of blockbuster drugs developed by other companies such as Bayer and Merck at much lower prices. Its generic business in the U.S., the world’s biggest pharmaceutical market, is sizable, and some 86% of its global sales come from outside India.
One-Year Total Return: 25%Corporate Snapshot: stockmarket.businessweek.comSite: www.drreddys.com
